NeuroPace Inc (NPCE): Kapitalisasi marang pendapatan

Simbol lan logo merek NeuroPace Inc (NPCE)

NeuroPace, Inc. (NPCE) relies on transparent guidance and the expansion of insurance coverage. System assembly is automated by robots, although device configuration remains the responsibility of medical professionals. The uniqueness of the therapy provides the company with premium pricing power. The latest value is recorded as 4.20, which clearly demonstrates the divergence of the P/S ratio from its historical average on this chart.

NPCE Multiplikator P/S NeuroPace Inc (04.07.2022 - 13.11.2026)

Rincian analitis perusahaan NeuroPace Corp (NPCE)

- rega saham lan konsensus proyeksi valuasi:
Analisis umum perusahaan:NPCE neuropace.com
Barang utama NeuroPace, Inc.

To minimize the risk of overpaying, an investor should correlate the market capitalization of NeuroPace, Inc. (NPCE) with its actual sales using the P/S business valuation on the GURU.Markets platform. This indicator captures price fluctuations against static revenue, which is critical for a company generating long-term cash flows through the monopolization of the RNS systems market and the regular replacement of implant components.

Pesaing NeuroPace, Inc.

DXCM (dexcom.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Penumbra PEN|NOVT - Kapitalisasi marang pendapatan|Haemonetics Corp. - Multiplikator P/S|Rega marang dodolan Inspire Medical Systems Inc|PRCT: Multiplikator P/S|Rasio kapitalisasi marang pendapatan CNMD|PLSE (Pulse Biosciences) - Multiplikator P/S|InMode Ltd (INMD) - Koefisien rega marang pendapatan|Multiplikator P/S PMI|Kapitalisasi marang pendapatan Surmodics Inc. SRDX|Multiplikator P/S SENS (Senseonics Holdings)|Multiplikator P/S Tactile Systems Technology, Inc. TCMD|SNWV - Rasio rega marang pendapatan|OM: Rasio rega marang pendapatan|ELMD (smartvest.com) - Kapitalisasi marang pendapatan|LENSAR Inc - Rasio kapitalisasi pasar marang pendapatan|RCEL (AVITA Medical, Inc.) - Multiplikator P/S|Rega marang dodolan Profound Medical Corporation PROF|Rasio rega marang pendapatan Baird Medical Investment (BDMD)|edap-tms.com (EDAP) - Multiplikator rega marang pendapatan|Apyx Medical Corporation - Kapitalisasi marang pendapatan|Multiplikator P/S IceCure Medical Ltd. ICCM|Pulmonx Corp. - Multiplikator P/S|Koefisien rega marang pendapatan TELA Bio, Inc. TELA|cytosorbents.com (CTSO) - Rasio rega marang pendapatan|Rasio rega marang dodolan SRTS (Sensus Healthcare Inc)|Rasio rega marang pendapatan Zynex Inc|Kapitalisasi marang pendapatan electroCore Medical (ECOR)|Multiplikator P/S RBOT|IINN - Rega marang dodolan|Rasio rega marang pendapatan SeaStar Medical ICU|IRIX: Rasio kapitalisasi marang pendapatan|INBS: Kapitalisasi marang pendapatan|Beyond Air, Inc. - Kapitalisasi marang volume dodolan|Profusa Inc (PFSA) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan SSKN|GCTK (GlucoTrack, Inc.) - Multiplikator P/S|Rega marang dodolan nanovibronix.com NAOV|Kapitalisasi marang pendapatan VERO (Venus Concept Corp)|Multiplikator P/S Nuwellis Corp (NUWE)|Rasio rega marang pendapatan Aethlon Medical AEMD|Rasio kapitalisasi pasar marang pendapatan ASXC|AVGR - Rasio rega marang pendapatan|Rega marang dodolan BioSig|Cutera, Inc (CUTR) - Rasio rega marang pendapatan|Rasio rega marang dodolan KNW (Know Labs Corporation)|NARI (Inari Medical, Inc.) - Multiplikator P/S|Multiplikator P/S nevro.com|Multiplikator P/S RSLS|Kapitalisasi marang pendapatan Silk Road Medical, Inc. SILK